TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
2 hedge funds and large institutions have $120 invested in TC BioPharm (Holdings) plc American Depositary Shares in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
94% less capital invested
Capital invested by funds: $2.05K → $120 (-$1.93K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
-$3.32K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$9 |
TCBP Hedge Fund Activity: Q2 2025 in Review
2 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q2 2025, worth a combined $120 — down 94% from $2.05K a quarter earlier.
Fund positioning in TCBP was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was GAMMA Investing, cutting an estimated $3.32K.
- 2 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $120 of TC BioPharm (Holdings) plc American Depositary Shares stock for Q2 2025, down 94% quarter-over-quarter.
- 0 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q2 2025 and 0 closed out.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q2 2025 was GAMMA Investing, an estimated $3.32K sold.
Based on aggregated 13F filings for Q2 2025.